MedTrace Logo

Safety and Efficacy of Heparin Dosing Score Protocol for Polymyxin-B Hemoperfusion

NCT03177330 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2017-06-06

No results posted yet for this study

Summary

Polymyxin B hemoperfusion (PMX-HP) is mainly used to remove endotoxins in septic shock patients with intra-abdominal infections. Because of the concerns of postoperative bleeding, physicians may hesitate to use anticoagulation in patients with septic shock within a few hours after an abdominal operation. We developed a heparin dosing score protocol for heparin dosage adjustment. The purpose of the study is to examine the safety and efficacy of the heparin dosing score protocol.

Conditions

  • Septic Shock
  • Polymyxin B Hemoperfusion

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Eligibility

Min Age
20 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-15
Primary Completion
2017-07-31
Completion
2017-07-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03177330 on ClinicalTrials.gov